Progressive degeneration of the retinal nerve fiber layer in patients with multiple sclerosis

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 13, 2012, Pages 8344-8349

  Herrero, Raquel ^a,b   Garcia Martin, Elena ^a,b   Almarcegui, Carmen ^a,b   Ara, Jose R ^a,b   Rodriguez Mena, Diego ^a,b   Martin, Jesus ^a,b   Otin, Sofia ^a   Satue, Maria ^a,b   Pablo, Luis E ^a,b   Fernandez, Francisco J ^a,b  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^b INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL LOSS; COLOR VISION TEST; CONTROLLED STUDY; EVOKED VISUAL RESPONSE; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA DEGENERATION; RETINA MACULA LUTEA; RETINA NERVE CELL; RETINAL NERVE FIBER LAYER THICKNESS; VISUAL ACUITY; VISUAL FIELD;

AXONS; DISEASE PROGRESSION; EVOKED POTENTIALS, VISUAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MULTIPLE SCLEROSIS; OPTIC NERVE DISEASES; PROSPECTIVE STUDIES; RETINAL DEGENERATION; RETINAL GANGLION CELLS; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 84873391310     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-10362     Document Type: Article

References (44)

1. Palace J. Inflammation versus neurodegeneration: consequences for treatment. J Neurol Sci. 2007;259:46-49.
2. Hauser SL, Oksenberg JR. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron. 2006;52:61-76.
3. Khanifar AA, Parlitsis GJ, Ehrlich JR, et al. Retinal nerve fiber layer evaluation in multiple sclerosis with spectral domain optical coherence tomography. Clin Ophthalmol. 2010;4: 1007-1013.
4. Sergott RC. Optical coherence tomography: measuring in-vivo axonal survival and neuroprotection in multiple sclerosis and optic neuritis. Curr Opin Ophthalmol. 2005;16:346-350.
5. Zaveri MS, Conger A, Salter A, et al. Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis. Arch Neurol. 2008; 65:924-928.
6. Gundogan FC, Demirkaya S, Sobaci G. Is optical coherence tomography really a new biomarker candidate in multiple sclerosis? A structural and functional evaluation. Invest Ophthalmol Vis Sci. 2007;48:5773-5781.
7. Garcia-Martin E, Pueyo V, Martin J, et al. Progressive changes in the retinal nerve fiber layer in patients with multiple sclerosis. Eur J Ophthalmol. 2010;20:167-173.
8. Garcia-Martin E, Pueyo V, Pinilla I, Ara JR, Martin J, Fernandez J. Fourier-domain OCT in multiple sclerosis patients: reproducibility and ability to detect retinal nerve fiber layer atrophy. Invest Ophthalmol Vis Sci. 2011;52:4124-4131.
9. Henderson AP, Trip SA, Schlottmann PG, et al. A preliminary longitudinal study of the retinal nerve fiber layer in progressive multiple sclerosis. J Neurol. 2010;257:1083-1091.
10. Ratchford JN, Quigg ME, Conger A, et al. Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies. Neurology. 2009;73:302-308.
11. Syc SB, Warner CV, Hiremath GS, et al. Reproducibility of highresolution optical coherence tomography in multiple sclerosis. Mult Scler. 2010;16:829-839.
12. Pueyo V, Martin J, Fernandez J, et al. Axonal loss in the retinal nerve fiber layer in patients with multiple sclerosis. Mult Scler. 2008;14:609-614.
13. Pueyo V, Polo V, Larrosa JM, Mayoral F, Ferreras A, Honrubia FM. Reproducibility of optic nerve head and retinal nerve fiber layer thickness measurements using optical coherence tomography. Arch Soc Esp Oftalmol. 2006;81:205-211.
14. Garcia-Martin E, Pueyo V, Ara JR, et al. Effect of optic neuritis on progressive axonal damage in multiple sclerosis patients. Mult Scler. 2011;17:830-837.
15. Frohman EM, Dwyer MG, Frohman T, et al. Relationship of optic nerve and brain conventional and non-conventional MRI measures and retinal nerve fiber layer thickness, as assessed by OCT and GDx: a pilot study. J Neurol Sci. 2009;282:96-105.
16. Yi K, Mujat M, Park BH, et al. Spectral domain optical coherence tomography for quantitative evaluation of drusen and associated structural changes in non-neovascular agerelated macular degeneration. Br J Ophthalmol. 2009;93:176-181.
17. Wojtkowski M, Srinivasan V, Fujimoto JG, et al. Threedimensional retinal imaging with high-speed ultrahigh-resolution optical coherence tomography. Ophthalmology. 2005; 112:1734-1746.
18. You JW, Chen TC, Mujat M, Park BH, De Boer JF. Pulsed illumination spectral-domain optical coherence tomography for human retinal imaging. Opt Express. 2006;14:6739-6748.
19. Fjeldstad C, Bemben M, Pardo G. Reduced retinal nerve fiber layer and macular thickness in patients with multiple sclerosis with no history of optic neuritis identified by the use of spectral domain high-definition optical coherence tomography. J Clin Neurosci. 2011;18:1469-1472.
20. Garcia-Martin E, Pueyo V, Almarcegui C, et al. Risk factors for progressive axonal degeneration of the retinal nerve fibre layer in multiple sclerosis patients. Br J Ophthalmol. 2011;95: 1577-1582.
21. Serbecic N, Aboul-Enein F, Beutelspacher SC, et al. High resolution spectral domain optical coherence tomography (SD-OCT) in multiple sclerosis: the first follow up study over two years. PLoS One. 2011;6:e19843.
22. Beer S, Rösler KM, Hess CW. Diagnostic value of paraclinical tests in multiple sclerosis: relative sensitivities and specificities for reclassification according to the Poser committee criteria. J Neurol Neurosurg Psychiatry. 1995;59:152-199.
23. Almarcegui C, Dolz I, Pueyo V, et al. Correlation between functional and structural assessments of the optic nerve and retina in multiple sclerosis patients. Neurophysiol Clin. 2010; 40:129-135.
24. Parikh RS, Parikh SR, Sekhar GC, Prabakaran S, Babu JG, Thomas R. Normal age-related decay of retinal nerve fiber layer thickness. Ophthalmology. 2007;114:921-926.
25. Talman LS, Bisker ER, Sackel DJ, et al. Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis. Ann Neurol. 2010;67:749-760.
26. Dörr J, Wernecke KD, Bock M, et al. Association of retinal and macular damage with brain atrophy in multiple sclerosis. PLoS One. 2011;6:e18132.
27. Gordon-Lipkin E, Chodkowski B, Reich DS, et al. Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology. 2007;69:1603-1609.
28. Burkholder BM, Osborne B, Loguidice MJ, et al. Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosis. Arch Neurol. 2009;66:1366-1372.
29. Chen TC, Zeng A, Sun W, Mujat M, de Boer JF. Spectral domain optical coherence tomography and glaucoma. Int Ophthalmol Clin. 2008;48:29-45.
30. Garcia-Martin E, Pinilla I, Sancho E, et al. Optical coherence tomography in retinitis pigmentosa: reproducibility and capacity to detect macular and retinal nerve fiber layer thickness alterations. Retina. 2012;32:1581-1591.
31. Costa-Cunha LV, Cunha LP, Malta RF, Monteiro ML. Comparison of Fourier-domain and time-domain optical coherence tomography in the detection of band atrophy of the optic nerve. Am J Ophthalmol. 2009;147:56-63.
32. Costello F, Coupland S, Hodge W, et al. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol. 2006;59:963-969.
33. Noval S, Contreras I, Rebolleda G, Muñoz-Negrete FJ. Optical coherence tomography versus automated perimetry for follow-up of optic neuritis. Acta Ophthalmol Scand. 2006; 84:790-794.
34. Klistorner A, Arvind H, Garrick R, et al. Interrelationship of optical coherence tomography and multifocal visual-evoked potentials after optic neuritis. Invest Ophthalmol Vis Sci. 2010;51:2770-2777.
35. Gordon-Lipkin E, Chodkowski B, Reich DS, et al. Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology. 2007;69:1603-1609.
36. Fisher JB, Jacobs DA, Markowitz CE, et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology. 2006;113:324-332.
37. Grazioli E, Zivadinov R, Weinstock-Guttman B, et al. Retinal nerve fiber layer thickness is associated with brain MRI outcomes in multiple sclerosis. J Neurol Sci. 2008;268:12-17.
38. Iester M, Cioli F, Uccelli A, et al. Retinal nerve fibre layer measurements and optic nerve head analysis in multiple sclerosis patients. Eye. 2009;23:407-412.
39. Trip SA, Schlottmann PG, Jones SJ, et al. Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol. 2005;58:383-391.
40. Zaveri MS, Conger A, Salter A, et al. Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis. Arch Neurol. 2008; 65:924-928.
41. Balnyte R, Uloziene I, Rastenyte D, Vaitkus A, Malciene L, Laučkaite K. Diagnostic value of conventional visual evoked potentials applied to patients with multiple sclerosis. Medicina (Kaunas, Lithuania). 2011;47:263-269.
42. You Y, Klistorner A, Thie J, Graham SL. Latency delay of visual evoked potential is a real measurement of demyelination in a rat model of optic neuritis. Invest Ophthalmol Vis Sci. 2011; 52:6911-6918.
43. Halliday AM. Visual evoked potentials in demyelinating disease. Adv Neurol. 1981;31:201-215.
44. García-Martín E, Pueyo V, Fernández J, et al. Effect of treatment in loss of retinal nerve fibre layer in multiple sclerosis patients. Arch Soc Esp Oftalmol. 2010;85:209-214.